Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pneumonia IV: Management01:28

Pneumonia IV: Management

359
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
359
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

266
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
266
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.2K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.2K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

275
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
275
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

341
The pathophysiology of pneumonia involves the following steps:
341
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

227
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
227

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Maintenance DNA methylation is necessary for age-related alterations in regulatory T cell transcriptional and DNA methylation signatures.

bioRxiv : the preprint server for biology·2026
Same author

Predictive accuracy of population meropenem models in critically ill pneumonia patients.

Antimicrobial agents and chemotherapy·2026
Same author

Depiction of Delirium in Contemporary Medical Television Dramas: A Descriptive Content Analysis.

Journal of the American Geriatrics Society·2026
Same author

Large Language Models Provide Accurate but Potentially Unsafe Answers to Multimodal Critical Care Medicine Board Review Questions.

Critical care medicine·2026
Same author

Pathogen-specific host responses define distinct pneumonia endotypes in the human lung.

bioRxiv : the preprint server for biology·2026
Same author

Impact of Livestreaming Pre-Clerkship Lectures: A Prospective Pilot with Multiyear Follow-up.

Medical science educator·2026

相关实验视频

Updated: Jul 20, 2025

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

50.0K

对严重肺炎的裁决协议.

Chiagozie I Pickens1, Catherine A Gao1, Justin Bodner1

  • 1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Open forum infectious diseases
|July 31, 2023
PubMed
概括
此摘要是机器生成的。

开发严重肺炎的临床终点方案显示中等程度的同意. 7-8天的临床治愈与更好的患者结果有关,这表明它在重症肺炎研究中的有效性.

关键词:
进行裁决.临床临床临床临床临床临床临床终点终点终点的终点肺炎是一种肺炎.严重的严重的严重.

更多相关视频

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.3K
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.8K

相关实验视频

Last Updated: Jul 20, 2025

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

50.0K
Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.3K
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.8K

科学领域:

  • 肺部和重症监护医学 肺部和重症监护医学
  • 临床试验方法论 临床试验方法论
  • 传染性疾病 传染性疾病

背景情况:

  • 定义严重肺炎的成功治疗是具有挑战性的,因为潜在的偏见.
  • 在重症肺炎中确定有意义的临床终点的结构化方案的有效性需要进一步研究.

研究的目的:

  • 开发和评估严重细菌和/或病毒性肺炎的裁决方案.
  • 评估严重肺炎管理中的临床终点的可靠性和有效性.

主要方法:

  • 一个单中心前性队列研究,涉及医疗重症监护室中患有严重肺炎的患者.
  • 由两名,如果需要,三名肺部和重症监护医生对肺炎发作进行独立审查.
  • 对于未解决的裁决者之间的差异,共识审查.

主要成果:

  • 通过裁决协议,获得了适度的观察者间协议 (48.1%至78.8%).
  • 较低的协议与多次肺炎发作和共感染有关.
  • 在细菌性肺炎的第7至8天内获得的临床治愈与更高的活体分泌率相关 (OR,6.3;95% CI,3.5-11.6).

结论:

  • 一项针对重症肺炎的综合评判方案只产生了适度的观察者间共识.
  • 7-8天的临床治愈似乎是判断协议的有效和有意义的终点.
  • 这一发现支持使用早期临床治疗作为严重肺炎研究中有利结果的替代品.